BNTX
BioNTech SE
NASDAQ · Healthcare · Biotechnology · DE
$96.06
−2.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.18x
- Price / sales
- 7.95x
- Price / cash flow
- 28.53x
Enterprise value
- Enterprise value
- $13.3B
- EV / sales
- 4.39x
- EV / EBITDA
- -12.33x
- EV / EBIT
- -6.11x
- Market cap
- $24.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026